Otofonix Encore vs RCA In-Ear

The Otofonix Encore is a behind-the-ear prescription hearing aid priced at $295, placing it in the budget tier of the prescription category. In our lab testing, it earned a C grade with a SoundScore of 2.7/5, ranking 35th out of 36 prescription hearing aids tested. Sound performance presents significant challenges across most metrics. Speech clarity scores are low in both quiet (1.0/5) and noisy environments (1.0/5), falling 2.32 and 0.96 points below category averages respectively. Music streaming capability is essentially absent at 0.0/5, and own-voice comfort is notably limited at 0.1/5 in the tuned configuration—2.65 points below the category average. The one bright spot is feedback handling, which scores an excellent 4.7/5. While this falls just 0.01 points below the category average, it represents strong absolute performance that should minimize whistling issues during daily use. This device runs on disposable batteries. At this price point, shoppers should be aware that the RxEars Rxi offers substantially better sound performance (4.09/5) in the same price range. The Otofonix Encore may suit budget-conscious consumers who prioritize feedback stability over speech clarity and streaming features, but our testing suggests most users would benefit from considering higher-performing alternatives within this price tier.

The RCA In-Ear is a budget OTC hearing aid priced at $249, earning a C grade with a SoundScore of 2.8/5 in our lab testing. This places it near the bottom of the OTC category at #64 of 65 devices tested. Speech performance is a significant weakness for this device. Speech in quiet scores just 1.0/5, falling 1.79 points below the category average, while speech in noise also scores 1.0/5, sitting 0.48 points below average. These low absolute scores indicate limited benefit for understanding conversation in most listening situations. Music streaming scored 0.0/5, measuring 1.92 points below the category average—this device is not suitable for audio entertainment. The RCA In-Ear does show strength in feedback handling, scoring an excellent 5.0/5, which is 0.46 points above the category average. Own-voice comfort is mixed at 2.6/5, essentially matching the category average with only a 0.09-point advantage. The rechargeable battery design offers convenience for daily use. At this price point, consumers have substantially higher-performing alternatives. Devices like the Elehear Beyond (4.36/5), Apple AirPods Pro 2 (4.06/5), and several others in the same budget range deliver meaningfully better speech clarity and overall sound quality. The RCA In-Ear may appeal to those prioritizing feedback-free operation above all else, but most users seeking improved hearing will find better value elsewhere in the OTC market.